
Mastering CMC Quality Module 3 & QOS for NDA Submissions
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
This guide explains how to create a high-quality CMC Quality Module 3 and Quality Overall Summary (QOS) for a New Drug Application (NDA) submission to the FDA. It emphasizes the importance of these documents for regulatory compliance, accelerated approval, and demonstrating product quality. The guide provides a step-by-step process, including best practices and common pitfalls to avoid, and highlights the strategic role of the QOS in communicating with regulatory authorities. Ultimately, the text advocates for meticulous preparation and expert consultation to ensure a successful NDA submission. The target audience includes regulatory affairs professionals, CMC scientists, and pharmaceutical executives.
Support the show